<DOC>
	<DOCNO>NCT00215540</DOCNO>
	<brief_summary>SURFAXIN® ( lucinactant ) treatment examine low birth weight infant prevent development chronic lung disease , commonly know bronchopulmonary dysplasia ( BPD ) , premature infant require continued intubation receive surfactant prevention treatment respiratory distress syndrome ( RDS ) .</brief_summary>
	<brief_title>SURFAXIN® Treatment Prevention Bronchopulmonary Dysplasia ( BPD ) Very Low Birth Weight ( VLBW ) Infants .</brief_title>
	<detailed_description>Determine safety tolerability SURFAXIN administration first week life therapeutic approach prevention BPD . Determine whether treatment SURFAXIN first two three week life decrease proportion infant mechanical ventilation oxygen incidence death BPD VLBW infant assess 28 day life 36 week post-menstrual age ( determine need supplemental oxygen ) .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Premature infant 600 900 gram birth weight Intubated mechanical ventilation Sustained ( &gt; = 30 minute ) fraction inspire oxygen ( FiO₂ ) &gt; = 0.30 within 8 hour prior randomization Mother prolong rupture membrane ≥ 2 week Cultureproven sepsis High grade intraventricular hemorrhage ( IVH ) Congenital heart disease Congential anomalies inconsistent life likely confound efficacy safety endpoint FiO₂≥ 0.80 mean airway pressure ( MAP ) ≥ 12 cmH2O day life ( DOL ) 3 FiO₂ &lt; 0.25 time meeting entry criterion immediately prior randomization Concomitant use surfactant within first 48 hour life Prior use nitric oxide Prior use steroid Current participation clinical trial receive experimental drug use experimental device</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Days</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Double-blind</keyword>
	<keyword>Low Birth Weight</keyword>
	<keyword>Surfactant</keyword>
	<keyword>Placebo-Controlled</keyword>
	<keyword>Premature Birth</keyword>
</DOC>